Business StandardANAVEX® Life Sciences Corp.Jul 30, 20151 min readNew drug may boost brain power in Alzheimer’s patientsClick here to read article
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference